Pancreatic Safety of Sitagliptin in the TECOS Study

OBJECTIVE: We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i). RESEARCH DESIGN AND METHODS: In the Trial Evaluating Cardiovascular Outcomes w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Buse, John B., Bethel, M. Angelyn, Green, Jennifer B., Stevens, Susanna R., Lokhnygina, Yuliya, Aschner, Pablo, Grado, Carlos Raffo, Tankova, Tsvetalina, Wainstein, Julio, Josse, Robert, Lachin, John M., Engel, Samuel S., Patel, Keyur, Peterson, Eric D., Holman, Rury R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2017
Assuntos:
Clinical Care/Education/Nutrition/Psychosocial Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5864139/
https://ncbi.nlm.nih.gov/pubmed/27630212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-2780
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados